• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 PDSS-2 量表评估中国帕金森病患者的夜间症状:一项多中心横断面研究。

Evaluation of Nocturnal Symptoms in Chinese Parkinson's Disease Patients Based on the PDSS-2 Scale: A Multicenter Cross-Sectional Study.

机构信息

Department of Neurology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.

Department of Neurology, West China Hospital of Sichuan University, Sichuan, China.

出版信息

J Parkinsons Dis. 2023;13(6):1061-1071. doi: 10.3233/JPD-230060.

DOI:10.3233/JPD-230060
PMID:37522220
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10578254/
Abstract

BACKGROUND

Nocturnal symptoms have a significant effect on the quality of life in Parkinson's disease (PD) patients.

OBJECTIVE

This study aimed to investigate the prevalence and associated factors of nocturnal symptoms in Chinese PD patients.

METHODS

This multicenter cross-sectional study included 1,500 patients with primary PD from 18 centers in China was carried out between February 2019 and February 2020. Questionnaires including Parkinson's disease sleep scale 2 (PDSS-2), Parkinson's disease questionnaire 8 (PDQ-8), Beck depression inventory (BDI), and generalized anxiety disorder scale 7 (GAD-7) were used to assess nocturnal symptoms, quality of life, depression, and anxiety.

RESULTS

Among 1,500 Chinese PD patients, 576 (38.4%) reported nocturnal symptoms. Of them, 59.2% were older than 65 years. The PDQ-8 total score was higher in patients with nocturnal symptoms (p < 0.01). Moderate and severe depression was reported more often in patients with nocturnal symptoms (p < 0.01), and the occurrence and severity of anxiety were higher as well (p < 0.01). Longer disease duration and higher Hoehn-Yahr (HY) stage were independently associated with nocturnal symptoms (p < 0.01). Education level, depression, disease course, HY stage, and nocturnal symptoms were related to the quality of life in Chinese PD patients (p < 0.01).

CONCLUSION

Our study found that 38.4% of Chinese PD patients have nocturnal symptoms, even in early and mid-stage PD. Nocturnal symptoms were associated with worse quality of life and higher incidences of depression and anxiety. Nocturnal symptoms should be included in the assessment and care plan, especially in patients with longer disease courses and higher HY stages.

摘要

背景

夜间症状对帕金森病(PD)患者的生活质量有重大影响。

目的

本研究旨在调查中国 PD 患者夜间症状的患病率及相关因素。

方法

本多中心横断面研究纳入了来自中国 18 个中心的 1500 名原发性 PD 患者,于 2019 年 2 月至 2020 年 2 月进行。使用帕金森病睡眠量表 2(PDSS-2)、帕金森病问卷 8(PDQ-8)、贝克抑郁量表(BDI)和广泛性焦虑症量表 7(GAD-7)评估夜间症状、生活质量、抑郁和焦虑。

结果

在 1500 名中国 PD 患者中,576 名(38.4%)报告有夜间症状。其中,59.2%的患者年龄大于 65 岁。夜间症状患者的 PDQ-8 总分较高(p<0.01)。夜间症状患者中度和重度抑郁的报告更为常见(p<0.01),焦虑的发生和严重程度也更高(p<0.01)。较长的病程和较高的 Hoehn-Yahr(HY)分期与夜间症状独立相关(p<0.01)。教育程度、抑郁、病程、HY 分期和夜间症状与中国 PD 患者的生活质量相关(p<0.01)。

结论

本研究发现,38.4%的中国 PD 患者存在夜间症状,即使在早期和中期 PD 中也是如此。夜间症状与生活质量更差、抑郁和焦虑发生率更高相关。夜间症状应纳入评估和护理计划,尤其是在病程较长和 HY 分期较高的患者中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fca/10578254/04e48082c7fc/jpd-13-jpd230060-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fca/10578254/04e48082c7fc/jpd-13-jpd230060-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fca/10578254/04e48082c7fc/jpd-13-jpd230060-g001.jpg

相似文献

1
Evaluation of Nocturnal Symptoms in Chinese Parkinson's Disease Patients Based on the PDSS-2 Scale: A Multicenter Cross-Sectional Study.基于 PDSS-2 量表评估中国帕金森病患者的夜间症状:一项多中心横断面研究。
J Parkinsons Dis. 2023;13(6):1061-1071. doi: 10.3233/JPD-230060.
2
Prevalence and profile of nocturnal disturbances in Chinese patients with advanced-stage Parkinson's disease: a cross-sectional epidemiology study.中国晚期帕金森病患者夜间障碍的患病率和特征:一项横断面流行病学研究。
BMC Neurol. 2021 May 12;21(1):194. doi: 10.1186/s12883-021-02217-5.
3
Nocturnal disturbances and restlessness in Parkinson's disease: using the Japanese version of the Parkinson's disease sleep scale-2.帕金森病的夜间紊乱和不安:使用帕金森病睡眠量表-2 的日译本。
J Neurol Sci. 2012 Jul 15;318(1-2):76-81. doi: 10.1016/j.jns.2012.03.022. Epub 2012 Apr 23.
4
Validation of the nonmotor symptoms questionnaire for Parkinson's disease: results from a Chinese pilot study.帕金森病非运动症状问卷的验证:一项中国试点研究的结果
Int J Neurosci. 2015;125(12):929-35. doi: 10.3109/00207454.2014.986573. Epub 2014 Dec 18.
5
Autonomic Symptoms Correlate with Non-Autonomic Non-Motor Symptoms and Sleep Problems in Patients with Parkinson's Disease.自主神经症状与帕金森病患者的非自主非运动症状及睡眠问题相关。
Eur Neurol. 2018;80(3-4):193-199. doi: 10.1159/000495797. Epub 2018 Dec 20.
6
Impact of sleep quality on the quality of life of patients with Parkinson's disease: a questionnaire based study.睡眠质量对帕金森病患者生活质量的影响:一项基于问卷调查的研究。
Clin Neurol Neurosurg. 2016 Sep;148:29-34. doi: 10.1016/j.clineuro.2016.06.014. Epub 2016 Jun 23.
7
Sleep disturbances in Taiwanese patients with Parkinson's disease.台湾地区帕金森病患者的睡眠障碍。
Brain Behav. 2017 Sep 21;7(10):e00806. doi: 10.1002/brb3.806. eCollection 2017 Oct.
8
Parkinson's Disease Sleep Scale 2: application in an Italian population.帕金森病睡眠量表2:在意大利人群中的应用。
Neurol Sci. 2016 Feb;37(2):283-8. doi: 10.1007/s10072-015-2409-5. Epub 2015 Oct 31.
9
Depression and associated factors in nondemented Chinese patients with Parkinson's disease.非痴呆型中国帕金森病患者的抑郁及相关因素
Clin Neurol Neurosurg. 2017 Dec;163:142-148. doi: 10.1016/j.clineuro.2017.10.031. Epub 2017 Oct 31.
10
Prevalence and risk factors for depression and anxiety in Chinese patients with Parkinson disease.中国帕金森病患者抑郁和焦虑的患病率及相关因素。
BMC Geriatr. 2017 Nov 22;17(1):270. doi: 10.1186/s12877-017-0666-2.

引用本文的文献

1
The effect of Gua Sha therapy on Parkinson's disease with rapid eye movement sleep behavior disorder: a randomized controlled trial.刮痧疗法对帕金森病伴快速眼动睡眠行为障碍的影响:一项随机对照试验。
Neurol Sci. 2025 Jul 3. doi: 10.1007/s10072-025-08335-z.

本文引用的文献

1
Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson's disease.抗帕金森病药物可显著改善帕金森病患者的夜间睡眠。
PLoS One. 2021 Jul 28;16(7):e0255274. doi: 10.1371/journal.pone.0255274. eCollection 2021.
2
Current Update on Clinically Relevant Sleep Issues in Parkinson's Disease: A Narrative Review.目前帕金森病相关临床睡眠问题的最新研究进展:综述。
J Parkinsons Dis. 2021;11(3):971-992. doi: 10.3233/JPD-202425.
3
Update on the Management of Parkinson's Disease for General Neurologists.普通神经科医生帕金森病管理的最新进展
Parkinsons Dis. 2020 Mar 26;2020:9131474. doi: 10.1155/2020/9131474. eCollection 2020.
4
Subtypes of Sleep Disturbance in Parkinson's Disease Based on the Cross-Culturally Validated Korean Version of Parkinson's Disease Sleep Scale-2.基于经跨文化验证的帕金森病睡眠量表-2韩语版的帕金森病睡眠障碍亚型
J Clin Neurol. 2020 Jan;16(1):66-74. doi: 10.3988/jcn.2020.16.1.66.
5
Sleep in Parkinson's disease.帕金森病睡眠障碍。
Neuropsychopharmacology. 2020 Jan;45(1):121-128. doi: 10.1038/s41386-019-0448-y. Epub 2019 Jun 24.
6
Motor and non-motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel: final results of the GREENFIELD observational study.左旋多巴/卡比多巴肠凝胶治疗晚期帕金森病患者的运动和非运动结果:GREENFIELD 观察性研究的最终结果。
J Neurol. 2019 Sep;266(9):2164-2176. doi: 10.1007/s00415-019-09337-6. Epub 2019 May 27.
7
Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、地区和国家帕金森病负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2018 Nov;17(11):939-953. doi: 10.1016/S1474-4422(18)30295-3. Epub 2018 Oct 1.
8
Sleep and Parkinson Disease.睡眠与帕金森病
Mo Med. 2017 Sep-Oct;114(5):381-386.
9
Comparison of nocturnal symptoms in advanced Parkinson's disease patients with sleep disturbances: pramipexole sustained release versus immediate release formulations.晚期帕金森病伴睡眠障碍患者夜间症状的比较:普拉克索缓释制剂与速释制剂对比
Drug Des Devel Ther. 2018 Jul 4;12:2017-2024. doi: 10.2147/DDDT.S160300. eCollection 2018.
10
Analysis of nocturnal hypokinesia and sleep quality in Parkinson's disease.帕金森病患者夜间运动减少与睡眠质量的分析
J Clin Neurosci. 2018 Aug;54:96-101. doi: 10.1016/j.jocn.2018.06.016. Epub 2018 Jun 13.